Fortitude Family Office’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.45K | Sell |
18
-36
| -67% | -$18.9K | ﹤0.01% | 575 |
|
|
2025
Q1 | $34.2K | Hold |
54
| – | – | 0.01% | 289 |
|
|
2024
Q4 | $38.5K | Sell |
54
-2
| -4% | -$1.43K | 0.01% | 303 |
|
|
2024
Q3 | $58.9K | Hold |
56
| – | – | 0.02% | 217 |
|
|
2024
Q2 | $58.9K | Buy |
56
+21
| +60% | +$22.1K | 0.03% | 156 |
|
|
2024
Q1 | $33.7K | Hold |
35
| – | – | 0.02% | 199 |
|
|
2023
Q4 | $30.7K | Buy |
+35
| New | +$30.7K | 0.02% | 230 |
|